---
title: "Faeth Therapeutics grants new-hire stock options for 11,000 shares at $25.5 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295272053.md"
description: "Faeth Therapeutics granted stock options for 11,000 shares to two new employees under its 2026 Inducement Plan. The exercise price is $25.5 per share, matching the closing price on the grant date of August 4, 2026. Options vest with 25% after one year and monthly installments over 36 months, subject to continued service, with a 10-year term."
datetime: "2026-08-07T20:00:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295272053.md)
  - [en](https://longbridge.com/en/news/295272053.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295272053.md)
---

# Faeth Therapeutics grants new-hire stock options for 11,000 shares at $25.5 each

-   Faeth Therapeutics granted options covering 11,000 common shares to two new employees under its 2026 Inducement Plan, effective Aug. 4, 2026. \* Exercise price set at USD 25.5 per share, matching the stock’s closing price on the grant date. \* Vesting schedules 25% after one year from each employee’s start date, then monthly installments over 36 months, subject to continued service. \* Options carry a 10-year term from the grant date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via Business Wire (Ref. ID: 202608071600BIZWIRE\_USPR\_\_\_\_\_20260807\_BW022609) on August 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [FTH.US](https://longbridge.com/en/quote/FTH.US.md)

## Related News & Research

- [Faeth Therapeutics CFO Brian C. Stephenson files initial beneficial ownership statement](https://longbridge.com/en/news/290611234.md)
- [Pulse Biosciences grants inducement stock options for 16,950 shares at $44.92 each](https://longbridge.com/en/news/296217882.md)
- [Bicara awards CFO Jennifer Larson stock option for 285,000 shares at $24.63 each](https://longbridge.com/en/news/295935049.md)
- [EyePoint grants inducement stock options for 14,600 shares at $14.75 each](https://longbridge.com/en/news/295973158.md)
- [Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike price](https://longbridge.com/en/news/296264888.md)